NEW YORK (Reuters Health) – Duloxetine should be a first-line treatment for chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivors, according to updated guidelines from the American Society of Clinical Oncology (ASCO). “The most important messages from the guidelines are…
Read More
IDSA Updates COVID-19 Treatment Guidelines: Monoclonals and More
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. While there is still no “game-changer” for treating COVID-19, the Infectious Diseases Society of America (IDSA) continues to examine available and potential treatments as new evidence…
Read More
German Society Updates Rheumatic Diseases Guidelines in Light of SARS-CoV-2 Pandemic
NEW YORK (Reuters Health) – The German Society for Rheumatology (DGRh) has updated its guidelines to reflect the recent impact of the pandemic, noting among its key changes that anti-rheumatic medication should not be changed solely for fear of SARS-CoV-2…
Read More
What Drives Treatment Satisfaction Among Adults With AD?
Atopic dermatitis (AD) is associated with lower patient satisfaction scores in adults, suggesting there are unmet needs in clinical AD management. Satisfaction scores were higher when specialists prescribed systemic therapy, but were lower when nonspecialists prescribed systemic therapy and when…
Read More
New ASH Guidelines: VTE Prevention, Treatment in Cancer Patients
New guidelines from the American Society of Hematology “strongly recommend” using no thromboprophylaxis over using parenteral thromboprophylaxis in ambulatory patients receiving cancer chemotherapy who have low venous thromboembolism (VTE) risk, and using no thromboprophylaxis over oral thromboprophylaxis with vitamin K…
Read More
Vaccinating Teachers to Reopen Schools ‘Not Doable’
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Vaccinating all teachers against COVID-19 before schools reopen isn’t doable, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, said Wednesday. “If…
Read More